Findings

What do systematic reviews say?

4 questions · 4 findings · 3 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 0 · 0%GRADE not reported 2 · 50%Very low 1 · 25%Low 0 · 0%Moderate 1 · 25%High 0 · 0%

High‐dose vs low‐dose colchicine

Withdrawals due to adverse events · acute gout

1 finding from 1 review

Colchicine for acute gout 2021 · Cochrane Headline outcomes only
no estimate extracted
1 study · 126 participants
GRADE not reported

High‐concentration (8%) capsaicin patch vs control patch (0.4%)

Withdrawals due to adverse events · adults with postherpetic neuralgia

1 finding from 1 review

Topical capsaicin (high concentration) for chronic neuropathic pain in adults 2017 · Cochrane Headline outcomes only
no estimate extracted
8 studies · 2487 participants
Moderate

High‐dose colchicine vs placebo

Withdrawals due to adverse events · acute gout

1 finding from 1 review

Colchicine for acute gout 2021 · Cochrane Headline outcomes only
no estimate extracted
1 study · 111 participants
GRADE not reported

High‐treatment‐dose vitamin D (greater than 1000 IU/day) vs low‐treatment‐dose vitamin D (400 IU/day to 1000 IU/day)

Withdrawals due to adverse events · people with inflammatory bowel disease

It is very uncertain whether high‐treatment‐dose vitamin D (greater than 1000 IU/day) changes withdrawals due to adverse events compared with low‐treatment‐dose vitamin D (400 IU/day to 1000 IU/day) (very low certainty).

1 finding from 1 review

Vitamin D for the treatment of inflammatory bowel disease 2023 · Cochrane Headline outcomes only
RR 0.89 [0.06, 13.08]
3 studies · 104 participants
Very low